POTASSIUM CITRATE
- Product NDC
- 71335-2871
- 11-digit product format
- 713352871
- Labeler code
- 71335
- Product ID
- 71335-2871_41d8fb94-18b5-a16b-e063-6394a90aee3d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- POTASSIUM CITRATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA206813
- Marketing category
- ANDA
- Marketing start
- 2017-11-01
- Substance
- POTASSIUM CITRATE
- Active strength
- 10 meq/1
- Pharmacologic classes
- Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| EE90ONI6FF | POTASSIUM CITRATE | 6100-05-6 | POTASSIUM CITRATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-2871-1 | 71335287101 | 100 TABLET in 1 BOTTLE (71335-2871-1) | 100 tablet | 2025-10-23 | No | No | Historical |